New Analyst Forecast: $DRI Given 'Overweight' Rating

Recent analyst ratings for $DRI are mixed, with KeyBanc issuing an 'Overweight' rating and a median price target of $213.0 based on four analyst targets. Congressional members have traded $DRI with roughly equal purchases and sales, while corporate insiders have heavily favored selling, with 21 sales versus zero purchases in the last six months. Hedge fund activity shows a split, with 488 institutional investors increasing and 457 decreasing their positions, including significant moves by Citadel Advisors and UBS Group AG.

Analysis

Recent analyst coverage on Darden Restaurants ($DRI) presents a predominantly positive outlook from Wall Street, with KeyBanc initiating an 'Overweight' rating, contributing to a tally of four buy-equivalent ratings against one 'Underperform' from Jefferies in the last several months. The median price target from four recent analyst reports stands at $213.0, with individual targets such as Guggenheim's $220.0 and Morgan Stanley's $217.0 suggesting potential upside. Congressional trading activity in $DRI has been minimal and balanced, with one purchase and one sale by a single representative in the past six months. However, a significant counter-signal emerges from insider trading, where executives have exclusively sold shares: 21 sales transactions and zero purchases were recorded over the last six months, amounting to substantial divestitures by key personnel including the CEO Ricardo Cardenas (20,518 shares for approximately $4.27 million) and other presidents of major brands. Institutional ownership changes are mixed; while 488 investors added to their $DRI positions, 457 reduced theirs. Notably, Citadel Advisors LLC significantly increased its stake by 1,294,559 shares (+1750.4%), whereas firms like UBS Group AG, Invesco Ltd., Renaissance Technologies LLC, and Samlyn Capital, LLC made substantial reductions or exited positions entirely. This divergence, coupled with a 'moderately negative' overall sentiment score of -0.4, indicates a cautious market perception despite positive analyst ratings.

Key Decisions for Investors

• Investors should weigh the bullish analyst ratings and price targets for $DRI against the considerable volume of insider sales, which could signal caution from those with intimate knowledge of the company.
• Monitor upcoming earnings releases and management guidance closely to reconcile the optimistic analyst outlook with the bearish insider sentiment and mixed institutional flows.
• Consider the 'moderately negative' sentiment and significant institutional divestitures by some large funds as potential indicators of underlying concerns or profit-taking, warranting a thorough risk assessment before increasing exposure.